Table 1.
Patient characteristics | Angioectasia group | Non-angioectasia group | P-value |
---|---|---|---|
(n = 64) | (n = 97) | ||
Sex | |||
Male | 39 | 57 | n.s |
Female | 25 | 40 | |
Age (years) | |||
Mean ± SD | 71.2 ± 13.9 | 63.4 ± 17.3 | <0.01 |
Median (range) | 75.5 (27–87) | 66 (17–85) | |
< 65 | 18 | 43 | <0.05 |
≧65 | 46 | 54 | |
OGIB type | |||
Occult | 15 | 20 | n.s |
Overt | 49 | 77 | |
Drug use | |||
Antithrombotic | |||
Yes | 20 | 18 | n.s |
No | 44 | 79 | |
NSAIDS | |||
Yes | 6 | 20 | n.s |
No | 58 | 77 | |
Underlying disease | |||
Cerebrovascular disease | |||
Yes | 6 | 8 | n.s |
No | 58 | 89 | |
Cardiovascular disease | |||
Yes | 27 | 19 | <0.01 |
No | 37 | 78 | |
Chronic renal failure | |||
Yes | 6 | 7 | n.s |
No | 58 | 90 | |
Hypertension | |||
Yes | 38 | 43 | n.s |
No | 26 | 54 | |
Dyslipidemia | |||
Yes | 9 | 10 | n.s |
No | 55 | 87 | |
Diabetes | |||
Yes | 15 | 16 | n.s |
No | 49 | 81 | |
Liver cirrhosis | |||
Yes | 15 | 6 | <0.01 |
No | 49 | 91 |
Abbreviations: OGIB obscure gastrointestinal bleeding; NSAIDS nonsteroidal anti-inflammatory drugs